RWJBarnabas Health and Rutgers Cancer Institute Executive Named to the Academy of Oncology Nurse and Patient Navigators Board of Trustees

Jeanne Silva, MSN, RN-BC, CN-BN, CMSRN Assistant Vice President, Oncology Access and Navigation, RWJBarnabas Health and Rutgers Cancer Institute, has been appointed as a Trustee-at-Large for the Academy of Oncology Nurse & Patient Navigators (AONN+). Silva was recognized for her leadership in building and transforming the Oncology Navigation Program at RWJBarnabas Health and Rutgers Cancer Institute, creating the gold standard for oncology navigation across the country.

RWJBarnabas Health and Rutgers Cancer Institute Expert Shares What Young Women Need to Know About Rising Breast Cancer Rates

More young women are being diagnosed with breast cancer in all racial and ethnic groups than in years past. While most people think of breast cancer as something that happens later in life, experts stress that younger women also need to be aware of their risks, symptoms, and the importance of knowing their own bodies. 

Lindsay Potdevin, MD, surgical oncologist in the Breast Cancer Program at Rutgers Cancer Institute and RWJBarnabas Health, shares more on what young women need to know about rising breast cancer rates.

Rutgers Cancer Institute and RWJBarnabas Health Neuro-Oncology Leader Recognized by National Women’s Organization 

Women Leaders in Oncology has named Morana Vojnic, MD, MBA, Director of Neuro-Oncology for Rutgers Cancer Institute and System Leader for Neuro-Oncology for RWJBarnabas Health, the 2025 Woman Oncologist of the Year. The award honors a senior professional who is a respected individual in her field and who has modeled excellence in leadership, and who exhibits strong business acumen and the ability to share her skills with others. Vojnic was presented the award September 27th, during the annual Leadership Empowerment and Development (LEAD) conference. 

RWJBarnabas Health and Rutgers Cancer Institute Commemorate 30 Years of Bone Marrow Transplant Care

RWJBarnabas Health and Rutgers Cancer Institute, in collaboration with Robert Wood Johnson University Hospital, are celebrating the 30th anniversary of the Transplant and Cellular Therapy Program, which has provided life-saving care to patients since 1995. The program’s first bone marrow transplant patient, Munson McLeod, was given six months to live in 1994 after being diagnosed with relapsed non-Hodgkin’s lymphoma. Thanks to an autologous stem cell transplant, he is alive today, a husband, father, and business owner. Today, the program provides patients access to advanced treatment options for blood cancers including autologous and allogeneic stem cell transplantation, CAR T-cell therapy, and gene therapy for sickle cell anemia and beta-thalassemia.